Recent Headlines
Pacific Biomarkers CSO Elizabeth T. Leary Co-Authors Paper in March Issue of Clinical Chemistry
Article Explores the Contribution of Assay Methodologies in Risk Classification for Cardiovascular Disease - March 11, 2011 - Pacific Biomarkers Inc
Florida’s Only Female Bariatric Surgeon Adopts SPIDER Surgical System
New technology allows Dr. Tiffany Jessee to perform gastric-band procedure entirely through one incision. - March 10, 2011 - TransEnterix
Golgi Complex Marker - TGN46 Antibody Launched by Novus Biologicals
Novus Biologicals announces the release of a new rabbit polyclonal TGN46 Antibody for Golgi complex research. - March 09, 2011 - Novus Biologicals
Fort Worth Bariatric Surgeon Adopts SPIDER® System for Gastric Banding
As both surgeon and gastric band patient, Dr. Adam Smith appreciates system’s fewer incisions. - March 04, 2011 - TransEnterix
Pacific Biomarkers’ Dr. Amar A. Sethi Recognized by R&D Directions as One of Nine “Most Notable People in R&D”
Vice President of R&D Singled Out For Work In Seeking Clues to Heart-Disease Risk - March 03, 2011 - Pacific Biomarkers Inc
AnaSpec Introduces Cherry™Express T7 Protein Expression Kits
AnaSpec, Eurogentec Group is pleased to introduce CherryTMExpress T7 Protein Express Kits from Eurogentec. The Cherry™Express kit allows direct visualization through the whole process of T7 protein expression, production and purification without the need for any special requirements or... - February 24, 2011 - AnaSpec, EGT Group
AnaSpec Showcases Premium Quality of Fluorescent Nucleic Acid Probes
AnaSpec is pleased to showcase a variety of premium quality stains, including cell-impermeant and cell-permeant nucleic acid stains. The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. - February 24, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends and Best Practices at DCAT Week
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. - February 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Mitegen Announces Release of MicroRT™ Aligner
Alignment tool for preparing mounted crystals for room and variable temperature X-ray diffraction. - February 22, 2011 - MiTeGen, LLC
University of Miami Surgeon Removes Kidney Through Patient’s Belly Button
Using SPIDER Surgical System, Dr. Raymond J. Leveillee performs UHealth’s first single-incision nephrectomy. - February 20, 2011 - TransEnterix
AnaSpec Signs Distribution Agreement with In Vitr
AnaSpec, Eurogentec Group and In Vitro have announced a non-exclusive distributor agreement that will allow In Vitro and its European branches to distribute AnaSpec’s catalog and custom products for Peptides, Fluorescent Dyes, Antibodies, Assay Kits, and Amino Acids throughout Europe. In... - February 18, 2011 - AnaSpec, EGT Group
AnaSpec Offers α & β-Synuclein Recombinant Proteins
AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli. α-Synuclein is a 140-amino acid... - February 18, 2011 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® SIRT2 Assay Kits Fluorimetric
Expanding on their offerings of long wavelength, highly sensitive SIRT assays, AnaSpec, Eurogentec Group, is pleased to release 2 assay kits for SIRT2, the SensoLyte® 520 FRET SIRT2 Assay Kit and the SensoLyte® Green SIRT2 Assay Kit. The substrate found in the SensoLyte® 520 FRET SIRT2... - February 16, 2011 - AnaSpec, EGT Group
Tocomin Palm Tocotrienol Complex Won Ingredient of 2010 Award
Tocomin was selected because it has cutting edge science; is effective and natural. - February 12, 2011 - Carotech Inc.
Aciont® CEO to Present at IN3 West Medical Device Conference
John Higuchi will present on behalf of Aciont Inc at the IN3 West Medical Device Conference in Las Vegas, NV on February 22, 2011. - February 10, 2011 - Aciont Inc.
Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
Oncolytics Biotech Inc. (“Oncolytics”) announced that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of... - February 04, 2011 - Oncolytics Biotech
Pacific Biomarkers Names Sheri’ DuMond as Its New Director of Business Development
Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has promoted Sheri’ DuMond to Director of Business Development following her role as Senior Associate Director of Business Development at... - February 04, 2011 - Pacific Biomarkers Inc
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
New Lin28 Antibody Announced by Novus Biologicals
Novus' new Lin28 antibody is useful for immunofluorescence, immunohistochemistry and Western blot. By Western blot, Lin28 antibodies recognize a band at approximately 29kDa. This new Lin28 antibody was validated by Western blot on NTERA-2 cell lysate and 293T cells overexpressing LIN28. - January 26, 2011 - Novus Biologicals
TransEnterix Lands Surgical Device Executive to Serve as Chief Technology Officer
Richard M. Mueller will oversee all aspects of company’s research and development, including rapid innovation. - January 24, 2011 - TransEnterix
AnaSpec Introduces Industry’s First Fluorimetric Assay - SensoLyte® Cathepsin G Kits
AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit. These long-wavelength, homogeneous assays are ideal for the screening of enzyme... - January 22, 2011 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Amino Acids
AnaSpec, Eurogentec Group, is pleased to highlight their wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis. PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple... - January 22, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development
OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Sustainable Now Technologies Appoints Ryan Dibble as Chief Financial Officer
Sustainable Now Technologies (SNT), a green technologies developer located in Signal Hill, California, has announced today the appointment of Ryan Dibble as Chief Financial Officer. - January 21, 2011 - Sustainable Now Technologies
Mitegen Appoints New CEO
Mitegen LLC (“Mitegen”, the “Company), a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced today that Robert Newman has been appointed... - January 19, 2011 - MiTeGen, LLC
Synpromics Appoints Andrei Lyne as CFO
Synpromics Ltd. is pleased to announce that Andrei Lyne has joined the company as Chief Financial Officer. The new appointment demonstrates Synpromics’s commitment to build a world-class management team to fully exploit the exciting potential of its innovative technology. - January 19, 2011 - Synpromics Ltd
Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study
The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech
Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts
Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011 - Pacific Biomarkers Inc
Fort Worth Bariatric Surgeon Adopts SPIDER® System for Gastric Banding
As both surgeon and gastric band patient, Dr. Adam Smith appreciates system’s fewer incisions - January 08, 2011 - TransEnterix
AnaSpec Introduces Industry’s First FRET-Based - SensoLyte® Green Elastase Assay Kits
AnaSpec, Eurogentec Group is pleased to introduce the SensoLyte® Green Elastase Assay Kit - the first FRET-based Elastase activity assay kit in the industry. This kit employs a natural substrate, elastin that is labeled with the 5-FAM fluorophore and the QXL™ 520 quencher. Proteolytic... - December 30, 2010 - AnaSpec, EGT Group
AnaSpec Expands Anti-GFP Collection – mAb & Chicken Polyclonal Antibodies
AnaSpec is pleased to expand their GFP antibodies offerings. The new GFP antibodies include two monoclonals raised in mouse and a third, a polyclonal raised in chicken. Purified green-fluorescent protein (GFP) was used as antigen. Antibody reactivity was confirmed by ELISA and specificity was... - December 30, 2010 - AnaSpec, EGT Group
AnaSpec Offers Double-Dye Oligo Synthesis Service
AnaSpec, Eurogentec Group is pleased to highlight our Double-Dye Oligo Synthesis Service. With over 20 years expertise of oligonucleotide synthesis, and Eurogentec production facilities in San Diego, California and Liege, Belgium, AnaSpec now offers the largest number of fluorescent reporters and... - December 22, 2010 - AnaSpec, EGT Group
AnaSpec Expands HCV NS3/4A Protease Selection
AnaSpec, Eurogentec Group is pleased to announce the expansion of their NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d. These recombinant HCV NS3/4A proteases are highly active and can be used with the SensoLyte® 490, 520, or 620 HCV Protease Assay Kits for... - December 22, 2010 - AnaSpec, EGT Group
Wockhardt Foundation & ONGC Come Together for Khel Khel Mein
ONGC partners for a noble cause with Wockhardt Foundation to help underprivileged children. - December 12, 2010 - Wockhardt Foundation
Anti-5-Methylcytidine Antibody from AnaSpec - Most Cited
AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research. 5-Methylcytidine is a modified base found in the DNA of plants and vertebrate. DNA methylation is a post-replication process... - December 11, 2010 - AnaSpec, EGT Group
AnaSpecs Offers Dyes for Labeling Amine- and Thiol-Modified Oligos
AnaSpec is pleased to highlight their own proprietary HiLyte Fluor dyes for labeling amine and thiol modified oligonucleotides from AnaSpec’s wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines. Fluorescent dye-labeled oligos are widely used as primers... - December 11, 2010 - AnaSpec, EGT Group
New THAP11 Antibody from Novus Biologicals
Novus Biologicals just announced a new THAP11 antibody (catalog # NBP1-49463). THAP11 antibodies, also known as Thanatos-associated protein 11 antibodies, are useful for cancer studies and stem cell research. THAP-11 is a regulator of embryonic stem cells and is in the same field as Oct4, Sox2 and Nanog. - December 09, 2010 - Novus Biologicals
RayBiotech Renews Biomarker Discovery Grants for 2011
RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011. RayBiotech will accept applications for pilot grants beginning in early 2011. Winning applicants will be eligible for restricted grants of $5,000 to $20,000 worth of RayBiotech products and/or services. This is the second year RayBiotech has sponsored these grants to demonstrate the application of antibody-based products to biomarker discovery. - December 04, 2010 - RayBiotech, Inc
AnaSpec Introduces Anti-MOG (1-125), Mouse Monoclonal
Being the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research, AnaSpec is pleased to announce the release of the mouse monoclonal Anti-MOG (1-125). Anti-MOG monoclonal antibody was produced by immunizing Balb/c mice with recombinant MOG... - November 14, 2010 - AnaSpec, EGT Group
AnaSpec Introduces Fluorescent Endothelin GO Peptides
AnaSpec is pleased to announce the release of new HiLyte Fluor™ 488 and 5-FAM labeled Endothelin peptides (human, bovine, porcine, rat) adding on its Endothelin peptides collection. Endothelins (ET) are highly potent vasoconstrictor proteins distributed throughout all areas of the body, and... - November 13, 2010 - AnaSpec, EGT Group
TransEnterix Wins Life Sciences Company Award from NCTA
For developing a new system that allows surgeons to operate entirely through a patient’s belly button, TransEnterix received the “Life Sciences Company” award Wednesday from the North Carolina Technology Association (NCTA). The prestigious award was conferred Nov. 10 during the... - November 13, 2010 - TransEnterix
NanoCor Therapeutics, Inc. is Awarded a Grant Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
NanoCor Therapeutics, Inc. (NanoCor) today announced the Company was awarded a grant under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP). The grant is being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care... - November 08, 2010 - NanoCor Therapeutics Inc.
Aciont® Awarded Two Qualifying Therapeutic Discovery Project Grants Totaling $489K
Aciont Inc. announced today that it has been awarded $488,958 to support two projects under the U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) program. Aciont submitted only the following two applications to the program of which both were funded at the maximum allocation... - November 05, 2010 - Aciont Inc.
Skyentia Technologies Receives QTDP Grant
Skyentia Technologies LLC has been awarded over $260,000 in qualified investment grants for biotechnology research and development through the Qualified Therapeutic Discovery Program. - November 05, 2010 - Skyentia Technologies
RayBiotech Launches Th17 Antibody Arrays for Immune Research
RayBiotech, Inc., the Protein Array Pioneer Company, today announced the release of several antibody array products that can detect up to 34 proteins related to the recently discovered Th17 lineage of immune cells. Th17 cells have been linked to the immune response to fungal and certain bacterial infections, as well being associated with several autoimmune diseases, including lupus, rheumatoid arthritis, Crohn's disease and multiple sclerosis. - November 03, 2010 - RayBiotech, Inc
Stemedica International Announces Joint Venture with AnC Bio Group to Manufacture Allogeneic Adult Stem Cells
Stemedica International, S.A., a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint venture with AnC Bio, a global manufacturer of stem cell-based products. The new venture, StemedicaAnC, will manufacture allogeneic adult stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. - October 24, 2010 - Stemedica Cell Techechnologies
Tocomin®SupraBio™ Boosts Immune Response in Human
Tocomin®SupraBio™ bioenhanced palm tocotrienol complex is effective in enhancing immune function in healthy women. - October 22, 2010 - Carotech Inc.
RayBiotech Awarded NIH/STTR Grant for Endometriosis Research
RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis. - October 22, 2010 - RayBiotech, Inc
AnaSpec Introduces SensoLyte® HAT (p300) & HAT (pCAF) Assay Kits
AnaSpec is pleased to announce the release of two HAT (histone acetyltransferase) fluorimetric kits adding in our growing list of epigenetics research products. The SensoLyte p300 Assay Kit provides a convenient assay for the screening of enzyme inhibitors and for continuous measurement of p300... - October 16, 2010 - AnaSpec, EGT Group
Stemedica Announces Completion of Clinical Allogeneic Adult Stem Cell Master Bank
A world leader in allogeneic adult stem cell manufacturing and research, Stemedica Cell Technologies, Inc. announced the completion of its proprietary master bank of mesenchymal bone marrow-derived stem cells. - October 15, 2010 - Stemedica Cell Techechnologies